Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Takeshi Kita; Taiji Sakamoto; Tatsuro Ishibashi

doi:10.1007/978-1-4939-1086-1_10

Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Takeshi Kita, Taiji Sakamoto, Tatsuro Ishibashi

Research output: Chapter in Book/Report/Conference proceeding › Chapter

15 Citations (Scopus)

Abstract

Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

Original language	English
Title of host publication	Vitreous
Subtitle of host publication	In Health and Disease
Publisher	Springer New York
Pages	151-164
Number of pages	14
ISBN (Electronic)	9781493910861
ISBN (Print)	9781493910854
DOIs	https://doi.org/10.1007/978-1-4939-1086-1_10
Publication status	Published - Jan 1 2014
Externally published	Yes

All Science Journal Classification (ASJC) codes

Medicine(all)

Access to Document

10.1007/978-1-4939-1086-1_10

Cite this

@inbook{9d9bb79fe1d64e419ddb5dba9d7c2b7f,

title = "Hyalocytes: Essential vitreous cells in vitreoretinal health and disease",

abstract = "Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.",

author = "Takeshi Kita and Taiji Sakamoto and Tatsuro Ishibashi",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1086-1_10",

language = "English",

isbn = "9781493910854",

pages = "151--164",

booktitle = "Vitreous",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Hyalocytes

T2 - Essential vitreous cells in vitreoretinal health and disease

AU - Kita, Takeshi

AU - Sakamoto, Taiji

AU - Ishibashi, Tatsuro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

AB - Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

UR - http://www.scopus.com/inward/record.url?scp=84956824766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956824766&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1086-1_10

DO - 10.1007/978-1-4939-1086-1_10

M3 - Chapter

AN - SCOPUS:84956824766

SN - 9781493910854

SP - 151

EP - 164

BT - Vitreous

PB - Springer New York

ER -

Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this